NZP manufactures a range of bulk pharmaceutical intermediates and pharmaceutical ingredients for supply to pharmaceutical and biotechnology companies worldwide.
Background to NZP
New Zealand Pharmaceuticals Ltd (NZP) was established in 1971 to extract and purify biochemicals from by-products of the New Zealand meat processing industry. In the 1980s the product range broadened to include a variety of other biochemicals, especially biopolymers, extracted from natural sources.
In recent years, NZP’s integrated cGMP manufacturing capability expanded into the chemical synthesis of carbohydrates, iminosugars, bile acid derivatives and other novel compounds with therapeutic potential.
In 2005, the private equity firm, Direct Capital www.directcapital.co.nz, purchased a 51% share of NZP.
Owing to a strong demand for derivatives of NZP’s bile acids and a range of carbohydrates, the Company developed synthesis capability. This capability was fully realised with the opening of a dedicated synthesis facility in 2007.
NZP is situated near the city of Palmerston North in the North Island of New Zealand. The city is home to New Zealand's largest university (Massey University) and New Zealand's largest concentration of life sciences and agricultural research.
NZP has won a number of business and export awards, for example, see http://www.nzte.govt.nz/section/11771/18220.aspx.
For further information on NZP, please visit www.nzp.co.nz.
The Global Market
The company is ranked in the New Zealand top 50 technology companies and exports over 99% of its products to all parts of the world.
Marketing and Quality
NZP’s success is built on excellent commercial relationships. It is highly customer focused and fosters close working collaborations in the;
· servicing of existing products
· development and manufacture of new products. 
As well as delivering products of the required quality, NZP strives to exceed customer service requirements through a commitment to timely communication, accurate export documentation and efficient worldwide distribution.
Good Manufacturing Practice
Current Good Manufacturing Practice (GMP) is an integral part of the company's culture and ensures that NZP's products conform to stringent customer specifications and comply with international regulatory requirements. The majority of the analytical testing is carried out in-house in a modern quality assurance laboratory.
Safety Health and Environment
Safety Health and Environmental (SH&E) issues are also fundamental to NZP's values. Driven by the safety vision of 'No Injuries to Anyone, Ever' a very safe working environment has been achieved. There is continuous investment at NZP to further improve both safety and the company's environmental footprint. New Zealand is a world leader in environmental protection and commitment to sustainability.
Product Development
The company fosters innovation throughout its operations and, places a high importance on product development. The company has well equipped laboratories and two pilot plants for small-scale commercial production.